News

NASM Introduces Groundbreaking Course on Weight Loss Medications

NASM Introduces Groundbreaking Course on Weight Loss Medications

Exciting Advances in Weight Loss Medication Education

The National Academy of Sports Medicine (NASM), a prominent name in fitness and wellness training, has introduced an innovative course aimed at helping fitness and wellness professionals. The course, titled "Understanding Weight Loss Medications: A Guide for Fitness and Wellness Professionals," is specifically designed to provide the tools and insights needed for professionals to support clients who are taking glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) medications. These medications have emerged as key players in managing weight and improving health for both individuals with and without type 2 diabetes.

The Rising Use of GLP-1 and GIP Medications

Weight loss medications like GLP-1 and GIP agonists are becoming increasingly common. Recent statistics reveal that approximately 8-12% of adults in the U.S. have trialed these medications, with about 6% currently using them. This noticeable shift highlights the importance of understanding these medications' role in our healthcare ecosystem.

Empowering Professionals Through Education

Mike Fantigrassi, Head of Product at NASM, emphasized the importance of education for fitness professionals as these medications gain traction among exercising populations. He stated, "It’s imperative for fitness and wellness professionals to be well-informed about these medications. Our new course offers comprehensive knowledge and tools to provide high-quality support, ensuring that exercise regimens are safely tailored to the diverse needs of clients on these medications. This understanding is vital for cultivating a secure and effective journey towards health and wellness."

Deep Dive Into Course Content

The course showcases evidence-based findings and developments in the world of GLP-1 and GIP medications. Participants will explore both currently FDA-approved medications and those that are in clinical trials. This wealth of knowledge is crucial, as it covers the pharmacology of medications like semaglutide and tirzepatide, including their mechanisms of action and potential side effects.

Course Objectives and Benefits

Attendees of the course can expect to achieve a comprehensive understanding of various topics including:

  • Identifying health risk factors associated with obesity.
  • Distinguishing between GLP-1 and GIP medications.
  • Understanding the benefits and common side effects of these medications.
  • Learning how to provide holistic support incorporating nutrition advice, exercise strategies, and behavioral coaching tailored to clients on these medications.

The course also discusses the indispensable role fitness and wellness professionals play in guiding clients undergoing medically assisted weight loss, and introduces strategies to promote sustainable lifestyle changes.

An Essential Resource for Wellness Professionals

NASM's "Understanding Weight Loss Medications" course aims to equip fitness and wellness professionals with the most relevant research and strategies necessary for helping clients navigate their weight loss journeys healthily and effectively. The course underscores NASM's commitment to evidence-based practices and ongoing professional development in the field of fitness and wellness.

About NASM

The National Academy of Sports Medicine is recognized as a global leader in certifications and education for fitness professionals, boasting more than 35 years of experience. Their programs empower trainers and coaches by combining practical knowledge and scientific research, enabling them to foster better performance and health in their clients. With innovative training methodologies like the Optimum Performance Training (OPT™) model, NASM continues to set standards in the fitness industry. For more detailed insights into NASM's offerings, visit their official website.

Frequently Asked Questions

What is the new course offered by NASM about?

The course titled "Understanding Weight Loss Medications" focuses on educating fitness and wellness professionals about glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide medications.

Who can benefit from this NASM course?

This course is designed for fitness and wellness professionals looking to enhance their knowledge about weight loss medications and how to support clients using them.

What topics are covered in the course?

Participants will learn about health risks, benefits and side effects of GLP-1 and GIP medications, along with nutrition and behavioral support strategies.

How does this course benefit fitness professionals?

The course equips fitness professionals with comprehensive insights, allowing them to safely guide clients on these medications and tailor exercise programs accordingly.

Where can I find more information about the course?

Further details and enrollment options can be found on the official NASM website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TCOM Secures $600M Deal to Boost NATO's Defense

Updated Category News Views 3

TCOM's Pivotal $600 Million Defense Contract How often do you hear about a deal north of $600 million that practically revamps a company's strategic future? That's precisely what's hitting the books at TCOM right now. They've scored a heavy-hitting Foreign Military Sales (FMS) contract to fortify NATO's eastern front with Poland. I'll tell you this—it’s one of the...

Continue Reading
Epson & The Photo Managers Highlight Memories in Sept.

Updated Category News Views 8

A Focus on Memory Preservation I remember a time when you kept memories in photo albums, dusty boxes in basements. Now, folks aim to digitize those moments before they're lost forever. With September here, Epson and The Photo Managers are telling us it's time for action. And hey, the campaign’s got a catchy name, 'One Photo, One Story.' Simple, yet it urges us all to...

Continue Reading
Zum Drivers Shine as New School Year Begins

Updated Category News Views 0

Opening the School Year with High Hopes Zum's crew of enthusiastic drivers hit the streets with a mission: kickstarting the new school year with a sense of excitement that feels fresh, even to a grizzled trader like me. These folks are doing more than just turning the ignition, they’re handling a vital cog in the education machine. From Fresno down to Rockford, you’ll...

Continue Reading
MacGregor's Bold Play: RoRo Tech for TT-Line's Ferries

Updated Category News Views 2

A Green Wave in the Baltic It looks like MacGregor's betting big on the future of maritime transport, and they're putting their chips down on TT-Line's next-gen battery-hybrid LNG ferries. With a contract fresh out of the oven, they've signed up to kit out these eco-warriors with a range of RoRo equipment. And let me tell you, this is no piddly order—by any stretch,...

Continue Reading
Supercharged Entertainment's Big Bet in Ohio's Polaris

Updated Category News Views 0

Fasten your seatbelts, folks—because there's a tinge of burnt rubber in the air at Columbus's Polaris Center. Supercharged Entertainment, the big guns in indoor karting, just kicked off construction at their brand-new venue, and it’s looking like a gearhead's paradise. A sprawling 16-acre parcel is set to become a haven for adrenaline junkies come Summer 2027. A Bold...

Continue Reading
Immunic Pushes Boundaries in MS with Vidofludimus

Updated Category News Views 1

Shaking Things Up in Multiple Sclerosis Therapy There's no telling how often the biotech sector tosses around the term 'game-changer,' but when Immunic's name comes up, more ears are perking up these days. The New York-based firm, waving the Nasdaq: IMUX flag, is lining up a virtual shindig come September 9, 2026, and for anyone invested in multiple sclerosis (MS) or...

Continue Reading
Axjo Group Expands in France with Eco-Tourets Buy

Updated Category News Views 6

Seizing the French Market: Axjo's Strategic Play Every now and then, you come across a company that's not just talking the talk but walking the green walk. Axjo Group's latest move—scooping up France's Eco-Tourets—puts them squarely in that league. It ain't just about expanding the footprint; it's about owning a piece of the future where sustainability isn't a...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
Early Education's Massive Impact: Key Skills for Success

Updated Category News Views 2

Unlocking Lifelong Success: The Early Advantage Ever look at a successful adult and wonder, "Where'd they get that spark?" According to HelloNation and child care expert Karen Ego, it all starts early. Think of early learning not just as prepping for school, but as the first blueprint for life's journey. It's the skills you pick up in those tender years that stick it out...

Continue Reading
Innventure Faces Class Action Over Alleged Deception

Updated Category News Views 3

Unpacking the Innventure Debacle Innventure, Inc. (NASDAQ:INV) seems to have landed itself in hot water, and not the relaxing kind. The revelation that its grand AI data center project in Ontario might never have existed has stirred up quite a storm among shareholders. This isn't just some run-of-the-mill oversight. We're talking about allegations of concocted stories...

Continue Reading

Top 5 Most Recently Viewed Articles

Zealand Pharma A/S Updates Share Count and Voting Rights

Updated Category News Views 86

Zealand Pharma A/S, a key player in the biotech sector out of Copenhagen, confirmed back in early 2024 that it had a total of 71,023,871 shares outstanding. Each share carries a nominal value of DKK 1. This number isn’t just a footnote—it’s vital for any stakeholder keeping tabs on their stake or those considering diving into this space. The company’s compliance...

Continue Reading
CS Genetics Introduces Innovative SimpleCell™ Genomics Kits

Updated Category News Views 146

CS Genetics Launches SimpleCell™ for Enhanced Single-Cell Genomics Single-cell genomics has entered a new era with the exciting launch of SimpleCell™ 3' Gene Expression kits by CS Genetics, a pioneer in the field. This innovative platform simplifies the process of single-cell transcriptomics, making it more accessible and scalable than ever before. The Power of...

Continue Reading
LifeMD's Engagement at the Upcoming Growth Conference

Updated Category News Views 117

LifeMD's Participation in a Major Growth Conference LifeMD, Inc. (Nasdaq: LFMD), a prominent provider in the domain of virtual primary healthcare, has announced its upcoming participation in the Canaccord Genuity 45th Annual Growth Conference. This well-regarded event will take place from August 12 to 14, offering a dynamic platform for dialogue between investors and...

Continue Reading
Exploring Embedded Finance in India: Growth Forecasts to 2029

Updated Category News Views 306

The Future of Embedded Finance in India The embedded finance industry in India is on a remarkable growth trajectory. As we look ahead to the years leading up to 2029, projections indicate a compound annual growth rate (CAGR) of 37.8%, with revenue climbing from US$5.75 billion in 2024 to an impressive US$28.6 billion by the end of the forecast period. Transformative...

Continue Reading
Revolutionizing 3D Modeling: Fixstars Unveils CUMVS Software

Updated Category News Views 179

Revolutionizing 3D Modeling with CUMVS Software Fixstars Corporation, a leader in AI-driven software development, recently made waves with the open-source release of its groundbreaking software, CUMVS (cuda-multi-view-stereo), designed for rapid 3D model generation from 2D images. This innovative software allows users to create digital twins of real-world objects, marking...

Continue Reading